Jillian A. Johnson

TL;DR: In this article, the authors provided updated clinical practice guidelines from the Society for Integrative Oncology on the use of integrative therapies for specific clinical indications during and after breast cancer treatment, including anxiety/stress, depression/mood disorders, fatigue, quality of life/physical functioning, chemotherapy-induced nausea and vomiting, lymphedema, chemotherapyinduced peripheral neuropathy, pain, and sleep disturbance.

TL;DR: The quality of the evidence supports a strong recommendation for the use of CBT-I among cancer survivors, and large effect sizes were observed for self-reported insomnia severity for those patients who received CBTs, representing a clinically relevant eight point reduction.

TL;DR: Results suggest that CBT-I is associated with statistically and clinically significant improvements in subjective sleep outcomes in patients with cancer and can be successfully delivered through a variety of treatment modalities, making it possible to reach a broader range of patients who may not have access to more traditional programs.

TL;DR: Preliminary evidence is provided for the feasibility and efficacy of a mindfulness intervention for the reduction of IBS symptom severity and symptoms of stress and the maintenance of these improvements at 6 months post-intervention.

TL;DR: Web-based PAJ may serve as an effective intervention for mitigating mental distress, increasing well-being, and enhancing physical functioning among medical populations, and is integrated into routine medical care to improve quality of life.